Abstract
Proteomic-based biomarker discovery approaches broadly attempt to identify proteins whose basal abundance, or change in abundance in response to a perturbation (e.g., a therapeutic intervention) is able to discriminate between populations of patients. Up until recently, the majority of approaches for discovering circulating biomarkers have focused on directly profiling serum or plasma to identify such proteins. However, the complexity and dynamic range of protein abundance in serum and plasma create a significant challenge for proteomics methods. To overcome these barriers, diverse approaches to simplify or to fractionate serum and plasma have been developed. For some diseases, such as those related to specific organs, there may be useful marker proteins that originate in the organ. Here, we describe an approach for marker discovery that focuses on the profiling of either primary tissue or cell culture models thereof.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gerber, S. A., Rush, J., Stemman, O., et al. (2003) Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS, Proc Natl Acad Sci U S A 100, 6940–6945.
Ong, S. E., Foster, L. J., and Mann, M. (2003) Mass spectrometric-based approaches in quantitative proteomics, Methods (San Diego, Calif 29, 124–130.
Durr, E., Yu, J., Krasinska, K. M., Carver, L. A., et al. (2004) Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture, Nature biotechnology 22, 985–992.
Wright, M. E., Eng, J., Sherman, J., et al. (2003) Identification of androgen-coregulated protein networks from the microsomes of human prostate cancer cells, Genome Âbiology 5, R4.
Ranish, J. A., Hahn, S., Lu, Y., et al. (2004) Identification of TFB5, a new component of general transcription and DNA repair factor IIH, Nature genetics 36, 707–713.
Blagoev, B., Kratchmarova, I., Ong, S. E., et al. (2003) A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling, Nature biotechnology 21, 315–318.
Andersen, J. S., Wilkinson, C. J., Mayor, T., et al. (2003) Proteomic characterization of the human centrosome by protein correlation profiling, Nature 426, 570–574.
Marko-Varga, G., Lindberg, H., Lofdahl, C. G., et al. (2005) Discovery of biomarker candidates within disease by protein profiling: principles and concepts, J Proteome Res 4, 1200–1212.
Kani, K., Faca, V. M., Hughes, L., et al. (2010) Proteomics reveals protein indicators of HER axis therapy response, submitted.
Wang, H., Clouthier, S. G., Galchev, V., et al. (2005) Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids, Mol Cell Proteomics 4, 618–625.
Wang, H., and Hanash, S. (2011) Intact-protein analysis system for discovery of serum-based disease biomarkers, Ed. Simpson RJ, Greening DW, Serum/Plasma Proteomics, Methods Mol Biol 728, Humana Press.
Faca, V. M., and Hanash, S. M. (2009) In-depth proteomics to define the cell surface and secretome of ovarian cancer cells and processes of protein shedding, Cancer Res 69, 728–730.
Zhou, Y., Aebersold, R., and Zhang, H. (2007) Isolation of N-linked glycopeptides from plasma, Anal Chem 79, 5826–5837.
Rauch, A., Bellew, M., Eng, J., et al. (2006) Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments, J Proteome Res 5, 112–121.
Keller, A., Nesvizhskii, A. I., Kolker, E., and Aebersold, R. (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search, Anal Chem 74, 5383–5392.
Nesvizhskii, A. I., Keller, A., Kolker, E., and Aebersold, R. (2003) A statistical model for identifying proteins by tandem mass Âspectrometry, Anal Chem 75, 4646–4658.
Ong, S. E., and Mann, M. (2006) A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC), Nat Protoc 1, 2650–2660.
Faca, V., Coram, M., Phanstiel, D., et al. (2006) Quantitative analysis of acrylamide labeled serum proteins by LC-MS/MS, J Proteome Res 5, 2009–2018.
Faca, V. M., Ventura, A. P., Fitzgibbon, M. P., et al. (2008) Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains, PLoS ONE 3, e2425.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Vogelsang, M.S., Kani, K., Katz, J.E., Mallick, P. (2011). Model-Based Discovery of Circulating Biomarkers. In: Simpson, R., Greening, D. (eds) Serum/Plasma Proteomics. Methods in Molecular Biology, vol 728. Humana Press. https://doi.org/10.1007/978-1-61779-068-3_5
Download citation
DOI: https://doi.org/10.1007/978-1-61779-068-3_5
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-067-6
Online ISBN: 978-1-61779-068-3
eBook Packages: Springer Protocols